Rodman & Renshaw Reiterates BioDelivery Sciences Market Outperform, $5.50 PT

Rodman & Renshaw reiterated its BioDelivery Sciences BDSI Market Outperform rating and $5.50 price target in a research report published today. In the report, Rodman & Renshaw states, "As we've noted since in our August 2010 initiation, we find more value in BDSI's pipeline than Onsolis has or could ever produce." Shares of BioDelievery Sciences were trading at $3.08 at the time of posting, down 4.80% from Thursday's market close.